Cercar
01/02/2025
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Torres, VE, Ahn, C, Barten, TRM, Brosnahan, G, Cadnapaphornchai, MA, Chapman, AB, Cornec-Le Gall, E, Drenth, JPH, Gansevoort, RT, Harris, PC, Harris, T, Horie, S, Liebau, MC, Liew, M, Mallett, AJ, Mei, CL, Mekahli, D, Odland, D, Ong, ACM, Onuchic, LF, Pei, YPC, Perrone, RD, Rangan, GK, Rayner, B, Torra, R, Balk, EM, Gordon, CE, Earley, A, Mustafa, RA, Devuyst, O. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. KIDNEY INTERNATIONAL. 2025; 107(2)DOI:10.1016/j.kint.2024.07.010. PMID:39848746. IF:12.600(Q1/1D).
07/01/2025
Clinical management of female patients with Fabry disease based on expert consensus
Brand, E, Linhart, A, Deegan, P, Jurcut, R, Pisani, A, Torra, R, Feldt-Rasmussen, U. Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03500-7. PMID:39773286. IF:3.500(Q2/4D).
01/01/2025
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry
Hughes, DA, Sunder-Plassmann, G, Jovanovic, A, Brand, E, West, ML, Bichet, DG, Pisani, A, Nowak, A, Torra, R, Khan, A, Azevedo, O, Lehman, A, Linhart, A, Rutecki, J, Giuliano, JD, Krusinska, E, Nordbeck, P. Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry. JOURNAL OF INHERITED METABOLIC DISEASE. 2025; 48(1)DOI:10.1002/jimd.12771. PMID:39031114. IF:3.800(Q2/3D).
01/01/2025
Genetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia
Riera-Escamilla, A, Arafa, MM, Farnetani, G, Xavier, MJ, Oud, MS, Majzoub, AA, Ramos, L, Abrardo, C, Spinelli, M, Moreno-Mendoza, D, Defazio, G, Ars, E, Pybus, M, Curbelo, JRS, Elbardisi, HT, Nawaz, S, Syed, N, Ruiz-Castané, E, van der Heijden, GW, Fakhro, KA, Veltman, JA, Krausz, C. Genetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia. Human Reproduction Open. 2025; 2025(3)DOI:10.1093/hropen/hoaf049. PMID:40896145. IF:11.100(Q1/1D).
01/12/2024
Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study
Blasco, M, Quiroga, B, García-Aznar, JM, Castro-Alonso, C, Fernández-Granados, SJ, Luna, E, Fresnedo, GF, Ossorio, M, Izquierdo, MJ, Sanchez-Ospina, D, Castañeda-Infante, L, Mouzo, R, Cao, M, Besada-Cerecedo, ML, Pan-Lizcano, R, Torra, R, Ortiz, A, de Sequera, P. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study. AMERICAN JOURNAL OF KIDNEY DISEASES. 2024; 84(6)DOI:10.1053/j.ajkd.2024.04.021. PMID:38972501. IF:8.200(Q1/1D).
01/12/2024
Intradialytic Parenteral Nutrition in Patients on Hemodialysis: A Multicenter Retrospective Study
Arias-Guillén, M, González, JC, Betancourt, L, Coll, E, Collado, S, Romano-Andrioni, B, Lupiañez-Barbero, A, Garro, J, Duarte, V, Soler-Majoral, J, Calabia, J. Intradialytic Parenteral Nutrition in Patients on Hemodialysis: A Multicenter Retrospective Study. Nutrients. 2024; 16(23)DOI:10.3390/nu16234018. PMID:39683411. IF:5.000(Q1/2D).
01/11/2024
Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome
El Bachouti, J, Domínguez-Guasch, A, Arce, Y, Oñate, G, Marco, H, Diaz, M, Guirado, L, Torra, R, Barros, X. Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216468. PMID:39518607. IF:2.900(Q1/2D).
01/11/2024
Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease
Coll, E, Cigarran, S, Portolés, J, Cases, A. Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease. Toxins. 2024; 16(11)DOI:10.3390/toxins16110495. PMID:39591250. IF:4.000(Q1/3D).
01/11/2024
Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT)
Draibe, JB, Marco, H, Ibernon, M, Agraz, I, Arcal, C, Barros, X, Cabrera, V, Da Silva, I, Díaz, M, Fulladosa, X, Guillén, E, Lescano, P, Valenzuela, LM, Márquez, E, Martin, N, Merino, A, Navarro, M, Rodríguez, E, Soler, MJ, Torras, J, Quintana, LF. Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT). Journal of Clinical Medicine. 2024; 13(22)DOI:10.3390/jcm13226793. PMID:39597938. IF:2.900(Q1/2D).
01/09/2024
Long-term outcome of NPHS2-related glomerulopathy
Lipska, B, Hofstetter, J, Trautmann, A, Boyer, O, Saleem, M, Tory, K, Ars, E, Dorval, G, Schaefer, F. Long-term outcome of NPHS2-related glomerulopathy. PEDIATRIC NEPHROLOGY. 2024; 39(1)DOI:. PMID:. IF:2.600(Q1/2D).
01/09/2024
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework
Duijzer, R, Bernts, LHP, Geerts, A, van Hoek, B, Coenraad, MJ, Rovers, C, Alvaro, D, Kuijper, EJ, Nevens, F, Halbritter, J, Colmenero, J, Kupcinskas, J, Salih, M, Hogan, MC, Ronot, M, Vilgrain, V, Hanemaaijer, NM, Kamath, PS, Strnad, P, Taubert, R, Gansevoort, R, Torra, R, Nadalin, S, Suwabe, T, Gevers, TJG, Cardinale, V, Drenth, JPH, Lantinga, MA. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00094-3. PMID:38878785. IF:38.600(Q1/1D).
01/07/2024
Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN
Blasco M., Quiroga B., García-Aznar J.M., Torra R., Ortiz A., de Sequera P.. Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN. NEFROLOGIA. 2024; 44(4)DOI:10.1016/j.nefro.2023.09.002. PMID:39054238. IF:2.600(Q2/4D).
01/07/2024
Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data
Salgueira, M, Almenara, M, Gutierrez-Pizarraya, A, Belmar, L, Labrador, PJ, Melero, R, Serrano, ML, Portoles, JM, Molina, A, Poch, E, Ramos, N, Lloret, MJ, Echarri, R, Mancebo, RD, Gonzalez-Lara, DM, Sanchez, JE, Soler, MJ. Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data. NEFROLOGIA. 2024; 44(4)DOI:10.1016/j.nefro.2023.03.008. PMID:. IF:2.600(Q2/4D).
30/05/2024
Ten tips on how to assess bone health in patients with chronic kidney disease
Jorgensen, HS, Lloret, MJ, Lalayiannis, AD, Shroff, R, Evenepoel, P. Ten tips on how to assess bone health in patients with chronic kidney disease. Clinical Kidney Journal. 2024; 17(5)DOI:10.1093/ckj/sfae093. PMID:38817914. IF:4.600(Q1/2D).
23/05/2024
Fibrosis and CD-163+macrophages: making a difference between MPO-AAV and PR3-AAV
Benito-Garcia, S, Vilardell, J, Arce, Y, Barros, X, Marco, H, Guirado, L, Encarnacion, MMD. Fibrosis and CD-163+macrophages: making a difference between MPO-AAV and PR3-AAV. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.324. PMID:. IF:5.600(Q1/1D).
23/05/2024
Comparative analysis of vitamin D status between patients with advanced chronic kidney disease and those on dialysis
Delgado, CM, Rodríguez, DL, Navarro-González, JF, Henriquez, F, Gilsanz, GD, Prieto, FJT, Jesus, LM, Morales, OS, Macia, M. Comparative analysis of vitamin D status between patients with advanced chronic kidney disease and those on dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.1481. PMID:. IF:5.600(Q1/1D).
23/05/2024
ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis
Jiménez, EM, Sanjuan, JB, Casado, E, García, MR, Lloret, MJ, Alonso, CC, Henriquez, F, Gifre, L, Calvo, JAH, Teruel, JLG, Gómez, C, Navarro-González, JF. ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.1471. PMID:. IF:5.600(Q1/1D).
23/05/2024
Impact of dialysis modality on bone phenotype
Lloret, MJ, Jorgensen, HS, Verhulst, A, Bammens, B, Claes, K, Devusser, K, Meijers, B, Van Craenenbroeck, A, De Loor, J, Cavalier, E, Evenepoel, P. Impact of dialysis modality on bone phenotype. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.856. PMID:. IF:5.600(Q1/1D).
23/05/2024
Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)
Brigl, C, Münster, J, Arjune, S, Demoulin, N, Gansevoort, R, Torra, R, Sans, L, Pamplona, IA, Sayer, J, Cornec-Le Gall, E, Hwang, DY, Halbritter, J. Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*). NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.005. PMID:. IF:5.600(Q1/1D).
01/05/2024
Different patterns of renal thrombotic microangiopathy
Guasch, AD, Arce, Y, El Bachouti, J, Tinoco, A, Pasache, HK, Basantes, AC, Marco, H, Torra, R, Guirado, L, Encarnacion, MMD, Barros, X. Different patterns of renal thrombotic microangiopathy. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.300. PMID:. IF:5.600(Q1/1D).
01/05/2024
Preimplantation genetic testing in inherited kidney diseases
Furlano, M, Tinoco, A, Sampani, E, Almeida, C, Goncalves, PL, Polo, A, Martínez, O, Teran, MP, Ramírez, ERV, Ars, E, Torra, R. Preimplantation genetic testing in inherited kidney diseases. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:. PMID:. IF:5.600(Q1/1D).
01/05/2024
Extent of proteinuria in autosomal dominant Alport syndrome compared to X linked Alport syndrome
Goncalves, PL, de Faria, VP, Furlano, M, Almeida, C, Sampani, E, Teran, MP, Viera, E, Fayos, L, Pybus, M, Aza, M, Ars, E, Torra, R. Extent of proteinuria in autosomal dominant Alport syndrome compared to X linked Alport syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.245. PMID:. IF:5.600(Q1/1D).
01/05/2024
Is class II lupus nephritis as benign as one thinks?
Goncalves, PL, Redondo, GB, Arce, Y, Magallares, B, Castellvi, I, Pasache, HK, Dominguez, A, Barros, X, Rusiñol, HM, Encarnacion, MMD. Is class II lupus nephritis as benign as one thinks?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.356. PMID:. IF:5.600(Q1/1D).
01/05/2024
Factors affecting disease progression in individuals with heterozygous COL4A3/COL4A4 pathogenic variants
Teran, MP, Furlano, M, Pybus, M, Jiménez, VM, Gomá-Garcés, E, Carrillo, IG, Leon, R, Romeo, MJS, de Arizón, LF, Perera, A, Ars, E, Torra, R. Factors affecting disease progression in individuals with heterozygous COL4A3/COL4A4 pathogenic variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:. PMID:. IF:5.600(Q1/1D).
01/05/2024
Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants
Zagorec, N, Calamel, A, Ars, E, Ong, A, Halbritter, J, Audrezet, MP, Pillay, VG, Meur, YL, Sayer, J, Cornec-Le Gall, E. Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.119. PMID:. IF:5.600(Q1/1D).
01/05/2024
Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling
Gosselink, ME, Snoek, R, Cerkauskaite-Kerpauskiene, A, van Bakel, SPJ, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, KJ, van Calsteren, K, Servais, A, de Jong, MFC, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, ER, Hall, M, Liu, LS, Hladunewich, MA, Lely, AT, van Eerde, AM. Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. KIDNEY INTERNATIONAL. 2024; 105(5)DOI:10.1016/j.kint.2024.01.034. PMID:38382843. IF:12.600(Q1/1D).
05/04/2024
Kidney health matters: a global imperative for public health
Torra, R. Kidney health matters: a global imperative for public health. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9)DOI:10.1093/ndt/gfae083. PMID:38578651. IF:5.600(Q1/1D).
01/03/2024
Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica
Bover J., Gómez-Alonso C., Casado E., Rodríguez-García M., Lloret M.J., Castro-Alonso C., Gifre L., Henríquez-Palop F., Prior-Español Á., López de la Manzanara V., Láiz A.M., Martínez-Ferrer À., Torregrosa J.V., Cigarrán S., Górriz J.L., Montomoli M., Panizo N., Costa E., Martínez-Laguna D., Rodríguez M., Navarro-González J.F.. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefro.2023.05.002. PMID:38531765. IF:2.600(Q2/4D).
01/03/2024
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?
Lloret, MJ, Jorgensen, HS, Evenepoel, P. Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?. Clinical Kidney Journal. 2024; 17(3)DOI:10.1093/ckj/sfae048. PMID:38500493. IF:4.600(Q1/2D).
01/03/2024
Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
Bover, J, Gómez-Alonso, C, Casado, E, Rodríguez-García, M, Lloret, MJ, Castro-Alonso, C, Gifre, L, Henríquez-Palop, F, Prior-Español, A, de la Manzanara, VL, Láiz, AM, Martínez-Ferrer, A, Torregrosa, JV, Cigarrán, S, Górriz, JL, Montomoli, M, Panizo, N, Costa, E, Martínez-Laguna, D, Rodríguez, M, Navarro-González, JF. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefroe.2024.03.005. PMID:. IF:2.600(Q2/4D).
14/02/2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial
Bais, T, Meijer, E, Kramers, BJ, Vart, P, Vervloet, M, Salih, M, Bammens, B, Demoulin, N, Todorova, P, Müller, RU, Halbritter, J, Paliege, A, Gall, ECL, Knebelmann, B, Torra, R, Ong, ACM, Frankl, FEK, Gansevoort, RT. HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials. 2024; 25(1)DOI:10.1186/s13063-024-07952-x. PMID:38355627. IF:2.000(Q3/7D).
01/02/2024
Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter
Lloret, MJ, Fusaro, M, Jorgensen, HS, Haarhaus, M, Gifre, L, Alfieri, CM, Masso, E, D'Marco, L, Evenepoel, P, Bover, J. Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter. Journal of Clinical Medicine. 2024; 13(4)DOI:10.3390/jcm13041010. PMID:38398323. IF:2.900(Q1/2D).
04/01/2024
Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective
Lomonte, C, Rossini, M, Ibeas, J, Forcella, M, Ponikvar, JB, Gallieni, M, Russo, R, Goumenos, D, Tesar, V, Hruskova, Z, Roelofs, J, Florquin, S, Snoeijs, M, Giusto, A, Shemesh, D, Rotmans, J, Torra, R, Wanner, C, Gesualdo, L. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective. Clinical Kidney Journal. 2024; 17(1)DOI:10.1093/ckj/sfad299. PMID:38213498. IF:4.600(Q1/2D).
01/01/2024
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD
Taylor J., Thomas R., Metherall P., van Gastel M., Cornec-Le Gall E., Caroli A., Furlano M., Demoulin N., Devuyst O., Winterbottom J., Torra R., Perico N., Le Meur Y., Schoenherr S., Forer L., Gansevoort R.T., Simms R.J., Ong A.C.M.. An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD. Kidney International Reports. 2024; 9(2)DOI:10.1016/j.ekir.2023.10.029. PMID:38344736. IF:5.700(Q1/1D).
01/01/2024
Influence of primary kidney disease in Chronic Kidney Disease pregnancies: pregnancy outcomes in women with COL4A3-5 related disease (Alport Syndrome)
Gosselink, M, Snoek, R, Cerkauskaite-Kerpauskiene, A, Van Bakel, S, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, K, Van Calsteren, K, Servais, A, de Jong, M, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, E, Hall, M, O'Neill, R, Hladunewich, M, Lely, T, van Eerde, AM. Influence of primary kidney disease in Chronic Kidney Disease pregnancies: pregnancy outcomes in women with COL4A3-5 related disease (Alport Syndrome). EUROPEAN JOURNAL OF HUMAN GENETICS. 2024; 32DOI:. PMID:. IF:4.600(Q1/2D).
01/01/2024
Acute kidney injury (AKI): Spanish nomenclature also matters here
Bover, J, Romero-González, G, Chávez-Iñiguez, JS, Rizo-Topete, L, Graterol, F, Santandreu, AV, Sanchez-Baya, M, Díaz, JM, Ortiz, A, Poch, YE. Acute kidney injury (AKI): Spanish nomenclature also matters here. NEFROLOGIA. 2024; 44(1)DOI:https://doi.org/10.1016/j.nefroe.2024.02.009. PMID:. IF:2.600(Q2/4D).
25/12/2023
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
Macia, M, Díaz-Encarnación, M, Solans-Laqué, R, Mallol, EP, Castells, AG, Escribano, C, de Arellano, AR. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 2023; 24(2)DOI:10.1080/14737167.2023.2297790. PMID:38126738. IF:1.800(Q3/6D).
09/11/2023
Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!
Torra, R, Kronbichler, A, Bajema, IM. Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!. Clinical Kidney Journal. 2023; 17(1)DOI:10.1093/ckj/sfad250. PMID:38186890. IF:3.900(Q1/2D).
01/10/2023
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).
29/09/2023
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
Lopez-Garcia, SC, Downie, ML, Kim, JS, Boyer, O, Walsh, SB, Nijenhuis, T, Papizh, S, Yadav, P, Reynolds, B, Decramer, S, Besouw, M, Carrascosa, MP, La Scola, C, Trepiccione, F, Ariceta, G, Hummel, A, Dossier, C, Sayer, JA, Konrad, M, Keijzer-Veen, MG, Awan, A, Basu, B, Chauveau, D, Madariaga, L, Koster-Kamphuis, L, Furlano, M, Zacchia, M, Marzuillo, P, Tse, Y, Dursun, I, Pinarbasi, AS, Tramma, D, Hoorn, EJ, Gokce, I, Nicholls, K, Eid, LA, Sartz, L, Riordan, M, Hooman, N, Printza, N, Bonny, O, Sancho, PA, Schild, R, Sinha, R, Guarino, S, Jimenez, VM, Peña, LR, Belge, H, Devuyst, O, Wlodkowski, T, Emma, F, Levtchenko, E, Knoers, NVAM, Bichet, DG, Schaefer, F, Kleta, R, European NDI Consortium, Bockenhauer, D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10)DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4.800(Q1/2D).